# FDG-PET-Stratified R-DICEP and R-Beam/ASCT For Diffuse Large B-Cell Lymphoma

> **NCT00530179** · NA · COMPLETED · sponsor: **AHS Cancer Control Alberta** · enrollment: 69 (actual)

## Conditions studied

- Diffuse Large B Cell Lymphoma

## Interventions

- **PROCEDURE:** Autologous Blood Stem Transplantation
- **DRUG:** R-CHOP

## Key facts

- **NCT ID:** NCT00530179
- **Lead sponsor:** AHS Cancer Control Alberta
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-07
- **Primary completion:** 2014-02
- **Final completion:** 2015-05-19
- **Target enrollment:** 69 (ACTUAL)
- **Last updated:** 2019-01-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00530179

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00530179, "FDG-PET-Stratified R-DICEP and R-Beam/ASCT For Diffuse Large B-Cell Lymphoma". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00530179. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*